185 related articles for article (PubMed ID: 31271560)
1. Metabolic profile, cardiovascular risk factors and health-related quality of life in children, adolescents and young adults with congenital adrenal hyperplasia.
Vijayan R; Bhavani N; Pavithran PV; Nair V; Menon UV; Menon AS; Abraham N; Bhadran K; Narayanan P; Kumar H
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):871-877. PubMed ID: 31271560
[TBL] [Abstract][Full Text] [Related]
2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
3. Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.
Ariyawatkul K; Tepmongkol S; Aroonparkmongkol S; Sahakitrungruang T
Eur J Pediatr; 2017 Apr; 176(4):537-545. PubMed ID: 28224294
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic Health in Adolescents and Young Adults with Congenital Adrenal Hyperplasia.
Navardauskaite R; Semeniene K; Sukys M; Pridotkaite A; Vanckaviciene A; Zilaitiene B; Verkauskiene R
Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454339
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory blood pressure and subclinical cardiovascular disease in patients with congenital adrenal hyperplasia: a preliminary report.
Akyürek N; Atabek ME; Eklioğlu BS; Alp H
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):13-8. PubMed ID: 25800471
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Sartorato P; Zulian E; Benedini S; Mariniello B; Schiavi F; Bilora F; Pozzan G; Greggio N; Pagnan A; Mantero F; Scaroni C
J Clin Endocrinol Metab; 2007 Mar; 92(3):1015-8. PubMed ID: 17200174
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Körner A; Kiess W; Kratzsch J; Dörr HG
Acta Paediatr; 2009 May; 98(5):885-91. PubMed ID: 19236311
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia.
Zainuddin AA; Grover SR; Abdul Ghani NA; Wu LL; Rasat R; Abdul Manaf MR; Shamsuddin K; Abdullah Mahdy Z
Health Qual Life Outcomes; 2020 Aug; 18(1):258. PubMed ID: 32738912
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.
Mooij CF; van Herwaarden AE; Sweep FCGJ; Roeleveld N; de Korte CL; Kapusta L; Claahsen-van der Grinten HL
J Pediatr Endocrinol Metab; 2017 Aug; 30(9):957-966. PubMed ID: 28787274
[TBL] [Abstract][Full Text] [Related]
10. Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.
Bonfig W; Roehl FW; Riedl S; Dörr HG; Bettendorf M; Brämswig J; Schönau E; Riepe F; Hauffa B; Holl RW; Mohnike K;
Am J Hypertens; 2016 Feb; 29(2):266-72. PubMed ID: 26071487
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia.
Marra AM; Improda N; Capalbo D; Salzano A; Arcopinto M; De Paulis A; Alessio M; Lenzi A; Isidori AM; Cittadini A; Salerno M
J Clin Endocrinol Metab; 2015 Feb; 100(2):644-52. PubMed ID: 25405496
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF; Charmandari E; Dattani MT; Hindmarsh PC
Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
[TBL] [Abstract][Full Text] [Related]
13. HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS WITH NONCLASSIC CONGENITAL ADRENAL HYPERPLASIA.
Brener A; Segev-Becker A; Weintrob N; Stein R; Interator H; Schachter-Davidov A; Israeli G; Elkon-Tamir E; Lebenthal Y; Eyal O; Oren A
Endocr Pract; 2019 Aug; 25(8):794-799. PubMed ID: 31013157
[No Abstract] [Full Text] [Related]
14. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
Ahmed SEAM; Soliman AT; Ramadan MA; Elawwa A; Abugabal AMS; Emam MHA; De Sanctis V
Acta Biomed; 2019 Sep; 90(3):360-369. PubMed ID: 31580328
[TBL] [Abstract][Full Text] [Related]
15. Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency?
Völkl TM; Simm D; Körner A; Rascher W; Kiess W; Kratzsch J; Dörr HG
Eur J Endocrinol; 2009 Feb; 160(2):239-47. PubMed ID: 19004982
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Rodrigues TM; Barra CB; Santos JL; Goulart EM; Ferreira AV; Silva IN
Arch Endocrinol Metab; 2015 Dec; 59(6):541-7. PubMed ID: 26677089
[TBL] [Abstract][Full Text] [Related]
17. Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil.
Gilban DL; Alves Junior PA; Beserra IC
Health Qual Life Outcomes; 2014 Aug; 12():107. PubMed ID: 25115634
[TBL] [Abstract][Full Text] [Related]
18. Assessment of health-related quality of life in Egyptian children and adolescents with congenital adrenal hyperplasia.
Musa N; Asem N; Basyony S; Fawaz L
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):295-304. PubMed ID: 32004147
[TBL] [Abstract][Full Text] [Related]
19. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Paizoni L; Auer MK; Schmidt H; Hübner A; Bidlingmaier M; Reisch N
J Steroid Biochem Mol Biol; 2020 Mar; 197():105540. PubMed ID: 31730799
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Subbarayan A; Dattani MT; Peters CJ; Hindmarsh PC
Clin Endocrinol (Oxf); 2014 Apr; 80(4):471-7. PubMed ID: 23751160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
